Insurance

Do you know that Medical Inflation in Singapore is 15% now? Part 1

What is medical inflation and should you be worried about it? Insurance products are designed to provide protection and give us a peace of mind. As the cost of medical products increases, it is important to note that insurance help to defray the costs to a certain extent too. Let us find out more in this article.

  • Fundsupermart
  • |
  • Published on 12 Aug 2016

Medical inflation loosely defined as cost of healthcare products is on the rise. Accordingly to a report by Aon Hewit1, the key highlights show that the average medical trend rate for 2016 is at 9.1%. What is more astonishing is that Singapore’s gross medical inflation is at 15%! Thus, the only way to hedge against it is to get yourself protected and do it as early as possible.

Insurance products are structured to provide protection at a cost. This protection also provides us the assurance that medical costs are covered for as long as we keep ourselves insured. Hence, we do not add on to the financial stress and mental burden of our family members and focus on getting ourselves treated.

Singapore’s core inflation rate (excluding costs of accommodation and private road transport) is at 1.1%2. This huge disparity between medical costs and core inflation is an indication that we need to select the right insurance product to protect ourselves from the rising costs.

So what should I get?

Fortunately, there are medical insurance products which are able to cover either part or the entire medical bill. For all Singaporeans and Singapore Permanent Residents, Medishield Life covers our basic healthcare costs if we are hospitalised in a public hospital. On top of that, consumers can opt to buy an Integrated Shield Plan (IP) offered by the private insurers and standalone Critical Illness plan (CI) which provides protection against major illnesses.

Though the premiums for these products will increase steadily as we age, this will be a small price to pay because we are transferring the financial risk to the insurers. We do not want to face a situation whereby our hard earned savings are eroded away by the high medical costs because we did not get ourselves protected with a medical insurance product. As previously mentioned in the earlier paragraph, the rising medical costs could pose as a financial risk to us and our family members if unforeseen circumstances do happen.

Here at Insurance@FSM, we strongly encourage you to review your insurance plans to make sure that you are adequately covered.

For any further enquiries, drop us an email at advisory@fundsupermart.com and our dedicated team of advisers will be happy to assist you.

Protect yourself and your loved ones now at Insurance@FSM!

1Source: Aon Hewit 2016 Global Medical Trend Rates

2Source: Consumer Price Develioments in June 2016


Related Articles:

With Medishield Life, do I still need an Integrated Shield Plan

Market Update - Medishield Life

All You need to Know About Health Insurance

Singapore 3M System and What You Need to Know

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.


Ways to Invest with FSM Global
Why FSM Global
Don't have an account with us?
Open an account here
Need Financial Advice?
Make an appointment
Related Articles More

We use cookies If you close this message or continue to use this site, you will consent to the use of Cookies, unless you choose to disable them. Click on our Privacy Policy to understand more.